Search
for
Sort by
Research 271–300 of 1000+
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Novel Clove Essential Oil Nanoemulgel Tailored by Taguchi’s Model and Scaffold-Based Nanofibers: Phytopharmaceuticals with Promising Potential as Cyclooxygenase-2 Inhibitors in External Inflammation
- The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
- The connection of 5-alpha reductase inhibitors to the development of depression
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Follikelhormone
- The PDE4 inhibitor, apremilast, suppresses experimentally induced alopecia areata in human skin in vivo
- Serum levels of interleukin-1 (IL-1α, IL-1β) in patients with alopecia areata
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Hedgehog Pathway Inhibitors against Tumor Microenvironment
- Under Development JAK Inhibitors for Dermatologic Diseases
- RETRACTED: Interleukin‐33 links asthma to alopecia areata: Mendelian randomization and mediation analysis
- Off-label dermatologic uses of IL-23 inhibitors
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Injury-induced interleukin-1 alpha promotes Lgr5 hair follicle stem cells de novo regeneration and proliferation via regulating regenerative microenvironment in mice
- Diabetes Mellitus Inhibits Hair Follicle Regeneration by Inducing Macrophage Reprogramming-Mediated Pyroptosis
- CXCL12+ dermal fibroblasts promote neutrophil recruitment and host defense by recognition of IL-17
- JAK inhibitors in dermatology: The promise of a new drug class
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Tyrosine kinase Inhibitors in Dermatology: A Systemic Review
- Interleukin-1 Induces Transcription of Keratin K6 in Human Epidermal Keratinocytes